Delivery Order SPE2DB22D9367-SPE2DB25FSX19
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trikafta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $137,029.08 and a completion date of November 1, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award is for the delivery of Trikafta, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $38,633.14 and a performance period ending on February 21, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the pharmaceutical product Trikafta, which is used to treat cystic fibrosis. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Trikafta. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans...
The federal contract award SPE2DX15D9168|SPE2DX25F6XCD, valued at $110,928.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Trikafta, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal...
This federal contract award is for delivery orders of the pharmaceutical product Trikafta 100-50-75 mg/150 mg under a firm fixed-price contract with the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract has a ceiling value of $36,637.50 and an ultimate completion date of September 12, 2023. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS...
This federal contract award is a delivery order (SPE2DX22FY9PH) valued at $82,463.32, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the procurement of Trikafta, a specialized pharmaceutical product, with a period of performance ending on March 2, 2022. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $18,488.12 for the pharmaceutical product Trikafta 100-50-75 mg/150 mg. The contract has a period of performance ending on February 27, 2025 and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Department of Defense (DOD) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The firm-fixed-price delivery order, valued at $72,575.66, is for the pharmaceutical product Trikafta 100-50-75 mg/150 mg, with a completion date of March 29, 2024. DMS Pharmaceutical Group holds a broader $4,999,999 indefinite delivery contract with the Defense Logistics Agency...
The federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the supply of TRIKAFTA 100-50-75 MG/150 MG pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue orders for a comprehensive...